Completed
Cobimetinib and Atezolizumab in Treating Participants With Advanced or Refractory Rare Tumors
NCT03108131
- Conditions
- Adenocarcinoma, Adenocarcinoma, Mucinous, Appendix Adenocarcinoma, +20 more
- Locations
-
- M D Anderson Cancer Center Houston, Texas, United States